Myxomatosis Vaccine

Myxomatosis is one of those diseases that every rabbit owner should know about, even if you have never seen a case firsthand. It is caused by the myxoma virus and spreads primarily through biting insects like fleas and mosquitoes, though direct contact between rabbits can also transmit it. In areas where myxomatosis is endemic, particularly the United Kingdom, Europe, and Australia, vaccination is considered an essential part of responsible rabbit ownership. The disease is nearly always fatal in unvaccinated domestic rabbits, which makes prevention the only realistic strategy for keeping your rabbits safe.

The availability and type of myxomatosis vaccine varies significantly depending on where you live. In the UK, a combined vaccine covering both myxomatosis and rabbit hemorrhagic disease is widely available and routinely administered by rabbit-savvy veterinarians. In the United States, no myxomatosis vaccine is currently licensed for use, which leaves American rabbit owners relying entirely on insect control and biosecurity measures. If you are in a region where vaccination is available, getting your rabbits vaccinated should be near the top of your priority list.

The severity of myxomatosis in unvaccinated rabbits cannot be overstated. Mortality rates in domestic rabbits who contract the virus approach ninety-five percent or higher, and the disease progression is painful and distressing for both the rabbit and the owner. Even rabbits who survive often face prolonged suffering and permanent health complications. Vaccination dramatically changes this picture, either preventing infection entirely or reducing the disease to a mild, manageable illness.

Rabbits are uniquely vulnerable to myxomatosis because the virus was specifically engineered to target them. It was deliberately released in Australia in the 1950s as a biological control agent for wild rabbit populations and later spread to Europe. This means the virus is exceptionally well adapted to exploiting rabbit physiology, and domestic rabbits have no natural resistance to fall back on. Unlike some diseases where a healthy immune system offers reasonable protection, myxomatosis overwhelms even the strongest unvaccinated rabbit.

This article covers what the myxomatosis vaccine does, who should get it, how the vaccination schedule works, what to expect after your rabbit is vaccinated, and what to do if you live in an area where the vaccine is not available. Whether you are a first-time rabbit owner or have kept rabbits for years, understanding this vaccine and its role in your rabbit's health plan is time well spent.

The primary reason your rabbit needs a myxomatosis vaccine is the virus itself, which circulates in wild rabbit populations across much of the world. The myxoma virus belongs to the poxvirus family and is remarkably resilient in the environment. It spreads mainly through the bites of fleas, mosquitoes, and other blood-sucking insects that feed on an infected rabbit and then bite a healthy one. This insect vector transmission is what makes the disease so difficult to control without vaccination, because even indoor rabbits can be bitten by a mosquito that found its way inside.

Direct contact between rabbits is another transmission route, particularly through nasal and eye secretions from infected animals. Rabbits living near wild populations or in areas with active outbreaks face higher risk simply because of proximity. Shared equipment, clothing, or hands that have touched an infected rabbit can also carry the virus, though insect transmission remains the dominant pathway. If you bring a new rabbit home without proper quarantine procedures, you risk introducing the virus to your existing rabbits.

Geographic location is the single biggest risk factor determining whether your rabbit needs the vaccine. In the UK and much of Europe, myxomatosis is endemic and outbreaks occur regularly, particularly during warmer months when insect populations peak. Australian rabbit owners face similar risks. In North America, the virus has been documented in wild populations along the West Coast and in parts of Mexico, but widespread outbreaks in domestic rabbits are less common. That said, the absence of a licensed vaccine in the US makes any exposure potentially catastrophic.

Seasonal patterns influence risk levels throughout the year. Late summer and autumn tend to bring the highest number of cases because flea and mosquito populations are at their peak. However, mild winters in many regions now mean that insects remain active for longer periods, extending the risk window. Outdoor rabbits and those housed in hutches with limited insect protection face the greatest exposure, but indoor rabbits are not immune to risk since insects can enter any home.

Rabbits who are unvaccinated, young, elderly, or immunocompromised face the highest danger from myxomatosis exposure. Breed does not appear to significantly influence susceptibility, as all domestic rabbit breeds are equally vulnerable to the virus. Rabbits living in multi-rabbit households face additional risk because a single infected individual can expose the entire group before symptoms become obvious.

Recognizing the early signs of myxomatosis matters even in vaccinated rabbits, because no vaccine provides absolute protection and breakthrough infections can occur. The earliest symptoms typically appear around five to fourteen days after infection and often start with puffy, swollen eyelids that give the rabbit a sleepy or squinting appearance. This swelling around the eyes is usually the first thing owners notice and should prompt immediate veterinary attention, especially during peak insect season.

As the disease progresses in unvaccinated rabbits, the swelling spreads to the entire face, ears, and genital area. The rabbit develops thick, milky discharge from the eyes and nose that crusts over and makes breathing difficult. Lumps and swellings may appear across the body, particularly around the head and base of the ears. The rabbit's skin can develop raised nodules that eventually ulcerate. The overall picture is a rabbit that looks increasingly miserable and uncomfortable as the virus takes hold.

Behavioral changes accompany the physical symptoms and often provide earlier warning than the visible swelling. An infected rabbit typically becomes lethargic and loses interest in food within the first few days. They may sit hunched in a corner rather than moving around their space normally. Reduced grooming is common as the rabbit feels increasingly unwell, and you may notice their coat looking rough or unkempt. Some rabbits develop a fever early in the infection that causes them to feel warm to the touch around the ears.

In vaccinated rabbits who experience a breakthrough infection, symptoms are usually much milder and may present as small skin nodules or scabs rather than the dramatic facial swelling seen in unvaccinated cases. These milder infections often resolve on their own or with supportive care, which is exactly why vaccination is so valuable even when it does not prevent every single infection. A vaccinated rabbit who develops a few bumps is in a completely different situation than an unvaccinated rabbit with full-blown myxomatosis.

The emergency signs that demand immediate veterinary intervention include severe facial swelling that closes the eyes completely, difficulty breathing due to nasal discharge and swelling, complete refusal to eat or drink, and any rapid deterioration in an already symptomatic rabbit. In unvaccinated rabbits with advanced myxomatosis, the prognosis is extremely poor, and the kindest option is often humane euthanasia to prevent further suffering. This is precisely why prevention through vaccination is so much more important than treatment after the fact.

Diagnosing myxomatosis is usually straightforward for a rabbit-savvy veterinarian based on the characteristic clinical signs, particularly the facial swelling, eye discharge, and skin nodules. Your vet will take a thorough history including vaccination status, potential insect exposure, and contact with other rabbits. In cases where the presentation is less obvious, particularly in vaccinated rabbits with mild symptoms, the vet may take swabs or tissue samples to confirm the presence of the myxoma virus through laboratory testing.

Blood work is not typically the primary diagnostic tool for myxomatosis, but your vet may run tests to assess your rabbit's overall condition and rule out other diseases that can cause similar symptoms. Pasteurella infections, rabbit syphilis, and abscesses can sometimes mimic early myxomatosis symptoms, so accurate diagnosis matters for choosing the right treatment approach. If your rabbit is vaccinated and showing mild signs, your vet will likely focus on confirming whether this is a breakthrough infection or something else entirely.

Treatment options for myxomatosis are limited because there is no antiviral medication that kills the myxoma virus directly. In vaccinated rabbits with mild breakthrough infections, supportive care is often sufficient and these rabbits generally recover well. Supportive care includes keeping the rabbit warm and comfortable, ensuring adequate food and water intake through syringe feeding if necessary, cleaning discharge from the eyes and nose to maintain breathing and vision, and administering anti-inflammatory medications to reduce swelling and pain.

Pain management is a critical component of caring for any rabbit with myxomatosis. The swelling and skin lesions are uncomfortable, and rabbits in pain stop eating, which creates a dangerous cascade of gut slowdown and dehydration. Your vet will likely prescribe a nonsteroidal anti-inflammatory medication safe for rabbits, and possibly additional pain relief depending on the severity. Antibiotics may also be prescribed not to treat the virus itself but to prevent secondary bacterial infections from taking hold in damaged skin and tissues.

The honest reality for unvaccinated rabbits with full-blown myxomatosis is that the prognosis is very poor. Most veterinarians will recommend euthanasia for severely affected unvaccinated rabbits because the mortality rate is extremely high and the suffering involved in the disease progression is significant. Attempting aggressive treatment in these cases rarely changes the outcome and extends the rabbit's distress. This is the hardest conversation to have, but it is also the most compelling argument for vaccination.

Recovery in vaccinated rabbits with mild cases typically takes two to four weeks with appropriate supportive care. During this time, the rabbit should be isolated from other rabbits to prevent transmission, kept in a warm and clean environment, and monitored closely for any worsening of symptoms. Follow-up veterinary visits ensure that the infection is resolving and that no secondary complications have developed. Most vaccinated rabbits who recover from a breakthrough infection develop even stronger immunity going forward.

If your rabbit is recovering from a mild myxomatosis infection, home care centers on keeping them comfortable and nourished while their immune system does the heavy lifting. Keep the recovery area warm, quiet, and clean, changing bedding daily to prevent secondary infections in any skin lesions. Gently clean discharge from around the eyes and nose with warm, damp cotton pads several times a day to keep airways clear and prevent crusting that blocks vision. Syringe feeding with a recovery formula like Critical Care may be necessary if your rabbit is not eating enough on their own, since maintaining gut function is always essential for rabbit health.

Administering medications as prescribed by your vet is straightforward once you get the hang of it. Most rabbit medications come as oral liquids that you give via a small syringe placed gently into the side of the mouth. Go slowly and let your rabbit swallow between small squirts rather than flooding their mouth. If your rabbit is on multiple medications, ask your vet about spacing them out rather than giving everything at once, which can be stressful for a rabbit who already feels unwell.

Prevention through vaccination is the cornerstone of protecting your rabbits from myxomatosis. In the UK, the Nobivac Myxo-RHD Plus vaccine covers both myxomatosis and both strains of rabbit hemorrhagic disease in a single annual injection. Rabbits can receive their first vaccination from five weeks of age, with annual boosters to maintain protection. Your vet may recommend boosting every six months in high-risk areas or during peak outbreak seasons. The vaccine is safe and well-tolerated by most rabbits, with occasional mild side effects like a small lump at the injection site that resolves within a few weeks.

Insect control is your second line of defense and becomes your primary protection if you live somewhere without access to the vaccine. Use insect screens on outdoor enclosures, apply rabbit-safe fly and mosquito repellents to housing areas, and treat your rabbits and their environment for fleas regularly using products recommended by your vet. Avoid letting rabbits graze in areas where wild rabbits are known to feed, particularly during dawn and dusk when mosquitoes are most active. Keeping your rabbit's living space clean and dry also discourages insect populations from establishing nearby.

Ongoing monitoring after vaccination means watching for any unusual symptoms even though your rabbit is protected. No vaccine is perfect, and staying aware of what myxomatosis looks like allows you to catch breakthrough infections early when they are most treatable. Keep records of your rabbit's vaccination dates and set reminders for annual or biannual boosters so protection never lapses. Talk to your vet about any local outbreaks and whether adjusting the vaccination schedule makes sense for your situation.

Get your rabbit to a rabbit-savvy vet immediately if you notice swelling around the eyes, face, or genital area, especially during warmer months when insect-borne transmission peaks. Thick discharge from the eyes or nose combined with lethargy and appetite loss should be treated as an emergency regardless of vaccination status. Do not wait to see if symptoms improve on their own, because in unvaccinated rabbits the disease progresses rapidly and every hour matters. Even vaccinated rabbits showing these signs need professional assessment to confirm whether it is a breakthrough infection or another condition.

Schedule a same-day appointment if your rabbit develops unexplained skin lumps or nodules, particularly if they appear in clusters or are located around the head and ears. A single small bump may be nothing, but multiple lesions appearing over a short period warrant investigation. Similarly, if your rabbit seems off, is eating less than normal, and you know there has been a local myxomatosis outbreak, do not dismiss the possibility just because your rabbit is vaccinated.

Finding a rabbit-savvy veterinarian before you need one is genuinely one of the best things you can do for your rabbits. Not every vet has experience with rabbit medicine, and myxomatosis in particular requires familiarity with the disease to make good treatment decisions quickly. Ask potential vets whether they regularly see rabbit patients, whether they stock rabbit-safe medications, and whether they are comfortable with the specific challenges of exotic animal medicine. The House Rabbit Society maintains a directory of recommended vets, and local rabbit rescue groups are often excellent sources for referrals.

The bottom line with myxomatosis is that prevention beats treatment every single time. If vaccination is available where you live, get it done and keep it current. If it is not available, invest seriously in insect control and biosecurity. And if you ever suspect your rabbit might be showing signs of this disease, get to the vet without hesitation. Your rabbit is counting on you to act fast.